Evidence map›Paper›PMID 20127226›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2010

Gene expression signatures in the peripheral blood after radiosurgery of human cerebral arteriovenous malformations.

Angelika Zabel-du Bois, Mechthild Wagner-Ecker, Stefanie Milker-Zabel, Christian Schwager, Ute Wirkner, Jürgen Debus, Amir Abdollahi, Peter E Huber

Abstract read
PubMed Publisher
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Radiosensitizing effect of the novel Hsp90 inhibitor NVP-AUY922 in human tumour cell lines silenced for Hsp90α.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2012
    Article
  5. Stereotactic LINAC radiosurgery for the treatment of brainstem cavernomas.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Angelika Zabel-du BoisDepartment of Radiation Oncology, German Cancer Research Center, Heidelberg, Germany. A.Zabel@dkfz-heidelberg.de.
Mechthild Wagner-EckerDepartment of Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
Stefanie Milker-ZabelDepartment of RadioOncology, University of Heidelberg, Heidelberg, Germany.
Christian SchwagerDepartment of Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
Ute WirknerDepartment of Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
Jürgen DebusDepartment of RadioOncology, University of Heidelberg, Heidelberg, Germany.
Amir AbdollahiDepartment of Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
Peter E HuberDepartment of Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
Heidelberg University · DEGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo unravel biological mechanisms potentially resulting in the obliteration process after radiosurgery (RS) of human cerebral arteriovenous malformations (AVMs) by investigating molecular signatures on the transcriptomic level in peripheral blood of patients. PATIENTS AND

methodsVenous blood samples were obtained at definite points of time before and after RS. The samples were tested for radiation-induced changes regarding biological markers (mRNA) using cDNA and oligo-microarray technology. The corresponding expression profiles were correlated with clinical data and obliteration signs in radiologic imaging.

resultsThe proof of principle that RS outcome can be successfully correlated with transcriptomics of cellular blood components as disease parameter was demonstrated. The authors identified 76 differentially regulated genes (p < 0.001) after RS. Interestingly, in particular genes with known roles in anti-angiogenic and pro-coagulative pathways were identified as potentially relevant. In particularly, the authors found a significant downregulation of neuropilin-2, protein C inhibitor and cyclin-dependent kinase 6. They also found that low pretreatment blood mRNA levels of TLR4 (toll-like receptor 4) and STAT3 (signal transducer and activator of transcription 3) correlated with fast obliteration of AVMs.

conclusionThe authors report on a novel technique for molecular biological analysis of blood from patients with cerebral AVM treated with RS. Differential regulation of genes in peripheral blood was successfully correlated with RS and time to obliteration of AVMs. The identified genes indicate a potential new methodology to monitor RS, which may result in an individualized therapy and optimized follow-up.

Indexed as

Gene Expression ProfilingRadiosurgeryAdultAgedBlood ProteinsCyclin-Dependent Kinase 6Down-RegulationFemaleHumansIntracranial Arteriovenous MalformationsMaleMiddle AgedNeuropilin-2Oligonucleotide Array Sequence AnalysisPrognosisProtein C InhibitorBlood ProteinsCyclin-Dependent Kinase 6Neuropilin-2Protein C InhibitorRNA, MessengerSTAT3 protein, humanSTAT3 Transcription FactorTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID20127226
OpenAlexW2117843535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.